Table 1.
Baseline demographics of the 486 INVEST-GENES participants
| Characteristics | This study (n=486) | INVEST (n=22,576) | p |
|---|---|---|---|
| Age, mean (SD), years | 66 (10) | 66 (10) | 0.42 |
| Women | 285 (59%) | 11770 (52%) | 0.23 |
| Baseline BP, mean (SD), mmHg | |||
| Systolic | 151 (18) | 148 (18) | 0.0001 |
| Diastolic | 87 (10) | 87 (12) | 0.0015 |
| Race/ethnicity | 0.0006 | ||
| White | 214 (44%) | 10925 (48%) | |
| Black | 77 (16%) | 3029 (13%) | |
| Hispanic | 189 (39%) | 8045 (36%) | |
| Other/multiracial | 6 (1%) | 577 (3%) | |
| BMI, mean (SD), kg/m2 | 30 (6) | 29 (7) | 0.04 |
| Smoking history | 189 (39%) | 2265 (41%) | 0.31 |
| Past Medical History | |||
| Myocardial infarction | 117 (24%) | 7218 (32%) | 0.65 |
| Angina pectoris | 348 (72%) | 15045 (67%) | 0.19 |
| Stroke/TIA | 38 (8%) | 1629 (7%) | 0.46 |
| Left ventricular hypertrophy | 88 (18%) | 4948 (22%) | 0.06 |
| Heart failure (class I-III) | 15 (3%) | 1256 (6%) | 0.73 |
| Peripheral vascular disease | 53 (11%) | 2699 (12%) | 0.91 |
| Diabetes | 137 (28%) | 6401 (28%) | 0.997 |
| Hypercholesterolemia | 254 (52%) | 12448 (55%) | 0.34 |
| Renal impairment | 8 (2%) | 424 (2%) | 0.9 |